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Mixed ligand complexes of transition metal ions exhibit broad range of biological activities. Schiff bases containing 
azomethine (C=N) group and amino acids are versatile compounds for design of ternary complexes. An attempt has been 
made to synthesize novel copper(I) complex by the reaction of two ligands, 2-N-(4-methyl phenyl ethanimine) 
benzimidazole [MPEIBI] as L1 and an amino acid Alanine as L2, and freshly prepared cuprous chloride solution in 1:1:1 
molar ratio through conventional reflux method. The synthesized ligand and copper(I) complex are characterized by 
elemental analysis, molecular weight determination, magnetic moment measurement, spectroscopic techniques. These 
synthesized compounds were evaluated for antimicrobial studies against bacterial strains, B. subtilis, E. coli and fungal 
pathogens, T. ressei, C. albicans. The Cu(I) complex has shown remarkable antibacterial and antifungal activity. 
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A novel concept of design of mixed ligand complexes 
of transition metal ions employing chelating ligands is 
far-reaching area of research as these are found to be 
biologically potent. Schiff based metal complexes are 
important and relevant compounds for current 
research in bioinorganic and medicinal chemistry
1
. 
Schiff bases are synthesized by condensation of 
primary amines with carbonyl compounds and form 
complexes with transition metals
2
. Benzimidazole 
based compounds are bioactive heterocyclic 
compounds
3
. Benzimidazole and its derivatives 
attracted more attention in the medical field due 
to their strong efficiency in biological and 
pharmacological areas
4
. Schiff bases of benzimidazole 
derivatives are also previously reported to possess a 

















activities etc. Amino acids are biologically significant 
compounds and have important biological 
applications
14
. Mixed ligand complexes play a 
significant role in biological process and exhibit 
higher antimicrobial activity than the free ligands 
because of chelation which decreases the polarity of 
the metal ions
15
. A brief literature summary on the 
medicinal and biological applications of Schiff based 
mixed ligand complexes have been recently 
reported
16
. Moreover, the azomethine functionality 
(-HC=N-) in the mentioned Schiff bases seems to be 
responsible for the various biological activities.  
Materials and Methods 
All the starting materials as well as solvents were 
of AR grade (purchased from Sigma Aldrich) and 
used without further purification. Elemental analysis 
of C, H, N and Cl were carried out by CHNX method. 
Molecular weights were estimated by Rast method. 
Cu metal was estimated gravimetrically. Melting 
points were recorded with open capillary tubes and 
are uncorrected. Reaction progress was monitored by 
thin layer chromatography (TLC) using silica gel-G 
plates and the purity of the synthesized compounds 
were checked by single spot TLC. Magnetic moment 
and molar conductance were measured by Gouy’s 
Balance Model no: HO-ED-EM-08 and Systronics 
Direct Reading Conductivity Meter-304 using glass 
cell (cell constant =1.0 cm
-1
) at room temperature, 





H NMR) was recorded on model Hitachi 
Perkin Elmer spectrometer using TMS as internal 
standard in DMSO-d6 and FTIR spectra was 
recorded on SHIMADZU-JAPAN 8400 FTIR 
spectrophotometer in region 4000-400 cm
-1
 (using 
KBr pellets). Mass spectrum was recorded on TOF 
MS ES, mass spectrometer operating at an ionization 
potential of 70 eV. 
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 2-N-(4-methyl phenyl 
ethanimine) benzimidazole [MPEIBI] ligand was 
prepared using equimolar mixture of 10 mL of 
4-methylacetophenone (1.34 g, 0.01 M) and 10 mL of
2-aminobenzimidazole (1.33 g, 0.01 M). This reaction
mixture was refluxed for ~ 6 h on heating mental in
presence of condensing agent and glacial acetic acid
and monitored by TLC using Silica Gel-G plate. After
completion of reaction, reaction mixture was cooled,
dried and recrystallized with alcohol then dried in
vacuum. We obtained pale yellow crystal with 55.4%
yield (m.p. 247.3 ℃).
Elemental analysis: for C16H15N3, calcd. (%): C 77, 
H 5.6, N 16.85; found (%): C 76.42, H 5.659, N 
16.80. IR IR (υ, cm
-1
): 1440 (C-Cstr), 814 (C-Cbend),
1552 (C=N), 2960 (C-Hstr). 
Synthesis of complex [CuL1L2] 
A fresh solution of CuCl (0.98 g, 0.01 M) was 
prepared in distilled water containing small amount of 
concentrated HCl. For complex formation 10 mL 
ethanolic solution of MPEIBI (2.49 g, 0.01 M) was 
mixed to 10 mL aqueous solution of L-alanine (0.89 g, 
0.01 M) and then 10 mL aqueous acidic solution of 
CuCl is added slowly with constant stirring. In this 
reaction mixture, metal to ligands molar ratio M:L1:L2 is 
1:1:1. This overall reaction mixture was stirred 
continuously but no precipitation was observed. The 
reaction mixture was refluxed for ~ 6 h and progress of 
reaction monitored by TLC. After completion of 
reaction, product was washed, recrystallized, dried and 
collected in vacuum. The reaction scheme is shown in 
Scheme 1. We obtained deep blue coloured product with 
49.35% yield. (m.p. 180.4 ℃). 
Elemental analysis: for CuC19H21N4O2, calcd. (%): 
C 56.91, H 5.27, N 13.97, Cu 15.85, , O 7.98; found (%): 
C 56.94, H 5.28, N 13.98, Cu 15.85, O 7.98. IR 
(υ, cm
-1
): 1402 (C-Cstr), 737 (C-Cbend), 1538 (C=N),
3076 (C-Hstr), 1605 (C=O), 609 (M-O), 465 (M-N). 
Antimicrobial studies 
In antibacterial analysis, in vitro antibacterial activity 
of the test compounds was screened by agar well 
diffusion method against gram-positive bacterium 
Bacillus subtilis and gram-negative bacterium 
Escherichia coli. Mueller Hinton agar used as the 
bacteria growth medium. Ciprofloxacin was used as 
standard antibacterial drug. The test samples were diluted 
in dimethylsulphoxide (DMSO) at the concentrations of 
1 mg/mL. The Mueller Hinton agar was melted and 
cooled to 48 – 50 ℃ and was poured on glass petriplates 
and was allowed to solidify. Standardized inoculum 
(1.5×108 CFU/mL, 0.5 Mc Farland) of the test organism 
was uniformly spread on the surface of these plates. 
Wells with diameter of 6 mm were prepared in the 
seeded agar plates. The test compound solution (20- 
80 µg/mL) was introduced in the well (6 mm). The agar 
plates were incubated overnight at 37 ℃ for 24 h. After 
incubation, clear zones were observed. The antibacterial 
activity was measured on the basis of diameter of 
bacterial growth inhibition zone (in mm). In antifungal 
analysis, in vitro antifungal activity of the synthesized 
compounds was investigated against two fungal species 
Trichoderma reesei and Candida albicans by agar well 
diffusion method. A sterile swab was used to distribute 
fungal culture evenly over the PDA agar medium and 
incubated at 37 
o
C for 24 h and 25 °C for 2-5 days, 
respectively. Ketoconazole used as standard antifungal 
drug. Suspensions of fungal spores were prepared in 
sterile PBS and adjusted to a concentration of 
106 cells/mL. Dipping a sterile swab into the fungal 
suspension and rolled on the surface of the agar medium. 
The plates were dried at room temperature for 15 min 
before use in the test. The test compound solution (20- 
80 µg/mL) at desired concentration was added to the well. 
The plates were incubated at 37 ℃. After incubation of  
2 days, the antifungal activities were determined by 
measuring the inhibition zones size (in mm). 
Results and Discussion 
Physicochemical analysis of complex showed that 
it is coloured and soluble in ethanol, DMF and 
Scheme 1 — Proposed synthetic route for mixed ligand complex 




DMSO. Molar conductance of complex measured in 







non-electrolytic nature of complex. Magnetic moment 
of complex found negligible which shows 
diamagnetic nature of complex.  
In FTIR spectra, shifting of absorption band to lower 
frequencies confirms coordination of C=N to metal ion. 
Similarly, the characteristic carboxylate υ(C=O) 
absorption band at 1720 cm
-1
 for alanine shift towards 
lower frequency region in complex that appears at 
1605 cm
-1










 correspond to M-N band as shown in Fig. 1. 
1
H NMR spectra of synthesized complex was 
recorded in solvent DMSO. We observed signals for 
Ar-H, CH3 (azomethine), CH3 (Ar-CH3), NH2 
(amine), NH (cyclic), CH (alanine), CH3 (alanine) at 
6.5-7.0 (multiplet), 1.7, 2.5, 4.4, 8.3, 3.6, and 1.2 
ppm, respectively, shows slightly lower field shift 
compare to ligand. (Fig. 2) 
 
 




Fig. 2 — 1H NMR spectrum of complex 




Mass spectrum of synthesized complex shows the 
investigated metal chelates. The mass spectrum of the 
complex provided a good evidence for its molecular 
formula CuC19H21N4O2 (MW 401.94). The ESI-MS 
spectrum of synthesized mixed ligand complex 
(CuC19H21N4O2) shows the molecular ion peak at m/z 
401.947 which is in good agreement with the 
calculated value for the molecular weight of the 
complex of 401.927 (Fig. 3). The found difference of 
about 0.02 between the observed and calculated 
molecular weight value is acceptable within the 
allowed experimental errors. In addition, other 
prominent peaks can also be observed in range  
m/z 85 to 402. 
Antimicrobial activity results are tabulated in  
Table 1 and shown in Fig. 4. Antimicrobial evaluation 
of synthesized ligand and complex shows remarkable 
activity for selected bacterial and fungal strain, 
Results reveal that the complex is more effective 
against E. coli but lesser effective for B. subtilis as 
 
 
Fig. 3 — Mass spectrum of complex 
 
Table 1 ― Antimicrobial and antifungal activities of compounds 
Compound Conc. (µg/µL) Zone of inhibition (mm) 
Antibacterial activity Antifungal activity 
B. subtilis E.coli T. reesei C. albicans 









































      
Standard 40   52*   46*   39**    32** 
*Ciprofloxacin,**Ketocanazole 




compared to synthesised ligand. Moreover, the 
complex shows significant inhibition effect for fungal 
strain i.e., T.reesei, but less activity for C. albicans. 
The antimicrobial data shows that the complex has an 
excellent biological activity against T. reesei with  
30 mm zone of inhibition at 80 µg/mL. The presence 
of clear zones shows that compounds are active. 
Overall, experimental results indicate that Cu(I) 
complex is more active towards most of the test 
microorganism than the ligand. Selected slides for 
antimicrobial studies of ligand and complex are 




Fig. 7 — Antifungal activity study of complex 
 
Conclusions 
On the basis of physicochemical analysis and 
spectral studies, four coordinated geometry has been 
expected for synthesized mixed ligand complex where 
the synthesized ligand act as bidentate chelating agent 
and the amino acid as mono-ionic bidentate moiety. 
Tetrahedral geometry has been proposed for 
synthesized complex and low conductance supports the 
non-electrolytic nature of the complex with 
diamagnetic nature. On the basis of FTIR data, no 
water molecule coordinated to metal ion was observed. 
In addition, it is observed that mostly, the Cu(I) 
complex exhibit more distinct antimicrobial activity 
against selective the bacterial and fungal pathogens 
compared to the free ligand. The enhancement in the 
antimicrobial activity may be rationalized on the basis 
that Cu(I) complex possesses azomethine (C=N) bond 
and donor atoms (nitrogen and oxygen) exhibiting 
more penetration effect for microbes either by killing 
them or through blocking their active sites. Moreover, 
our research continues for recognising the 
pharmacophore responsible for efficacy of the 
compound/complex. We emphasize our present work 
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